MOSSETTI, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 591
EU - Europa 238
AS - Asia 204
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.043
Nazione #
US - Stati Uniti d'America 584
IT - Italia 112
CN - Cina 102
SG - Singapore 98
NL - Olanda 34
FI - Finlandia 28
IE - Irlanda 26
DE - Germania 18
GB - Regno Unito 9
CI - Costa d'Avorio 8
CA - Canada 7
UA - Ucraina 5
SE - Svezia 4
DK - Danimarca 2
EU - Europa 2
IN - India 2
IR - Iran 1
TR - Turchia 1
Totale 1.043
Città #
Singapore 80
Chandler 68
Ashburn 50
Santa Clara 49
Millbury 41
Nanjing 38
Princeton 36
Amsterdam 34
Beijing 29
Boston 24
Jacksonville 22
Wilmington 19
Naples 14
Napoli 13
Woodbridge 12
Rome 10
Des Moines 8
Tianjin 7
Hebei 6
Nanchang 6
Ottawa 6
Los Angeles 4
Norwalk 4
Palermo 4
Shenyang 4
Washington 4
Augusta 3
Bari 3
Jiaxing 3
Turin 3
Arzano 2
Copenhagen 2
Dugenta 2
Ficarazzi 2
Lappeenranta 2
Ottaviano 2
Salerno 2
Ann Arbor 1
Capodrise 1
Caserta 1
Changchun 1
Changsha 1
Dearborn 1
Fairfield 1
Falls Church 1
Fremont 1
Grumo Nevano 1
Guangzhou 1
Hangzhou 1
Harbin 1
Houston 1
Indiana 1
Irsina 1
Kronberg 1
Lawrence 1
Nichelino 1
Orange 1
Padova 1
Prineville 1
Pune 1
Redmond 1
Reggio Nell'emilia 1
San Mateo 1
Seattle 1
Stockholm 1
Suffern 1
The Dalles 1
Toronto 1
Zhengzhou 1
Totale 650
Nome #
A functional allelic variant of the FGF23 gene is associated with renal phosphate leak in calcium nephrolithiasis. 51
Fibroblast growth factor 23 is increased in calcium nephrolithiasis with hypophosphatemia and renal phosphate leak� 46
Associazione tra sindrome metabolica e nefrolitiasi in un campione non selezionato di popolazione adulta dell'Italia Meridionale 41
A non-synonymous TNFRSF11A variation increases NFkB activity and the severity of Paget's disease. 40
Relationship between metabolic syndrome and multinodular non-toxic goiter in an inpatient population from a geographic area with moderate iodine deficiency 38
Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: role of gender, hypertension and abdominal obesity. 37
Effects of glucocorticoid therapy in giant cell tumor associated with Paget’s bone disease. A possible role of the Pai-Pa system 36
Genetica dell'FGF-23 nella nefrolitiasi 34
Clinical, historical and diagnostic findings associated with right ventricular dysfunction in patients with central and non-massive pulmonary embolism. 34
Association between the T716C missense mutation in the FGF23 gene and calcium nephrolithiasis with renal phosphate leak 33
Association between vitamin D receptor gene polymorphisms and tubular citrate handling in calcium nephrolithiasis 33
Bone turnover and the osteoprotegerin-RANKL pathway in tumor-induced osteomalacia: a longitudinal study of five cases. 32
Associazione tra sindrome metabolica e nefrolitiasi: ruolo di sesso, ipertensione ed obesità addominale 31
Association between vitamin D receptor gene polymorphisms and fasting idiopathic hypercalciuria in recurrent stone-forming patients. 31
Associazione tra la mutazione missense T716C del gene codificante per il fattore FGF23 e la nefrolitiasi calcica con perdita renale di fosfati 29
Biochemical markers of bone turnover, serum levels of interleukin-6/interleukin-6 soluble receptor and bisphosphonate treatment in Erdheim-Chester disease. 29
Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone. 28
Giant cell tumor and Paget's disease of bone in one family: geographic clustering 28
Metabolic Syndrome and nephrolithiasis: role of gender, hypertension and abdominal obesity 27
Vitamin D Receptor start codon polymorphism and parathormone serum levels in calcium nephrolithiasis 27
Evidence for increased clinical severity of familial and sporadic Paget's disease of bone in Campania, southern Italy. 26
Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates 26
Metabolic syndrome and nephrolithiasis: can we hypotize a common background? 26
Interleukin (IL)-6 and receptor activator of nuclear factor (NF)-κB ligand (RANKL) are increased in the serum of a patient with primary pachydermoperiostosis 26
Characteristic clinical and biochemical profile of recurrent calcium-oxalate nephrolithiasis in patients with metabolic syndrome. 25
Etiologic Aspects of Pagets Disease of Bone 24
Sindrome metabolica e nefrolitiasi asintomatica 23
SQSTM1 gene analysis and gene-environment interaction in paget's disease of bone 22
Epidemiological, clinical and genetic characteristics of Paget's disease of bone in a rural area of Calabria, Southern Italy 22
Diagnostic and therapeutic approach in patients with urinary calculi. 22
Vitamin D receptor gene polymorphisms predict acquired resistance to clodronate treatment in patients with Paget's disease of bone 21
FGF-23 gene alleles and renal phosphate leak in calcium nephrolithiasis 20
Phosphatonins: novel insights and clinical perspectives 19
The Melatonin Receptor 1A (MTNR1A) gene is associated with recurrent and idiopathic calcium nephrolithiasis. 19
Viral hepatitis in HIV infection 15
null 13
FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women 13
The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone 13
FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women 3
Clodronate treatment reduces serum levels of interleukin-6 soluble receptor in Paget's disease of bone 2
Effects of gluocorticoid therapy in giant cell tumor associated with Paget's bone disease. A possible role of the PAI-PA system 2
Totale 1.067
Categoria #
all - tutte 5.837
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.837


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202064 0 0 0 0 2 0 1 0 1 22 23 15
2020/202133 0 1 1 1 1 15 3 0 1 0 9 1
2021/2022209 3 0 0 3 0 3 0 9 31 2 63 95
2022/2023202 38 10 15 4 23 20 0 12 24 37 14 5
2023/2024211 4 39 17 22 27 25 11 13 3 5 36 9
2024/2025162 50 48 0 18 46 0 0 0 0 0 0 0
Totale 1.067